Xarelto is part of the new production of anti-coagulants that have been linked to fatal bleeding with no reversal agent causing a drug liability lawsuit.Our experienced attorneys may be able to get you the compensation you deserve.Pradaxa is not approved for use in people with artificial — or prosthetic — heart valves.Blood thinner medications are prescribed to patients to avoid clotting but can lead to dangerous side effects.Also in November 2012, Boehringer Ingelheim announced a nationwide voluntary recall of a single manufacturing lot of Pradaxa 75 mg capsules.
It is also important to know that Pradaxa can cause serious, sometimes fatal, bleeding.Individual Injury Lawsuits, Wrongful Death Lawsuits and Xarelto Class Action Lawsuits Reviewed by Lawyers for Bleeds, Hemorrhages. Learn More.
Recall Status: Nationwide recall in 2012 of a single manufacturing lot of Pradaxa 75 mg due to a potential packaging defect.As a result, it investigated the rates of gastrointestinal bleeding and intracranial hemorrhage (a type of bleeding in the brain) for new users of Pradaxa compared to new users of warfarin.In late 2011, Xarelto (rivaroxaban) joined the anticoagulant market.The views and opinions expressed on the site do not necessarily represent those of Drugwatch.
The study found an increased risk of major gastrointestinal bleeding with use of Pradaxa as compared to warfarin.The blood thinner Pradaxa did not have an antidote for its bleeding events until 2015, leading to hundreds of casualties and thousands of lawsuits.
Pradaxa is a type of anticoagulant (blood thinner) known as a direct thrombin inhibitor.These hematomas may result in long-term or permanent paralysis.If you or a family member has experienced complications from the use of Xarelto, Pradaxa, and Eliquis, call us.
Xarelto Lawsuit - Talk to a Board Certified Personal Injury Trial Lawyer with 30 years of Experience about your Xarelto Internal Bleeding Case.Thousands of lawsuits have been filed against the manufacturers of the drugs Xarelto and Pradaxa due to patients experiencing.So great was its competition that in 2013 it outsold Pradaxa two to one.The lawsuit says defendants failed to warn about dangerous side.
The safety announcement came after a clinical trial in Europe was halted because Pradaxa users with mechanical heart valves were more likely to suffer strokes, heart attacks and blood clots than those using warfarin.
It warned that a damaged bottle could allow moisture to get into the bottle, which could harm the quality of the drug.If not taken or prescribed correctly, it can increase the risk of dangerous bleeding.
The number of lawsuits will grow due because more people are taking the drug and have bad reactions.Blood thinners can prevent blood clots that lead to deep vein thrombosis, pulmonary embolisms and heart attacks.Pradaxa is also indicated to reduce the risk of DVT and PE recurring in patients who have been previously treated and to prevent DVT and PE in patients who have undergone hip replacement surgery.Bayer is now facing a Xarelto class action lawsuit in Canada, in addition to the ongoing multidistrict litigation in the Eastern District of Louisiana.